{
  "company": {
    "name": "Aquinnah Pharmaceuticals",
    "website": "https://aquinnahpharma.com/",
    "record": "https://startuphistory.org/c/aquinnahpharma.com"
  },
  "status": null,
  "history_since": "2026-11-12T11:53:07.844Z",
  "baseline": {
    "snapshot_id": "a87cb2d9670b056aa2ee16d11dfdca903e87033b8bfd415dbe2ca70ac22bd93c",
    "observed_at": "2026-11-12T11:53:07.844Z",
    "headline": null,
    "description": "A BOLD NEW APPROACH TO NEURODEGENERATIVE DISEASE - ALS and Alzheimer’s",
    "evidence": "https://www.aquinnahpharma.com/",
    "evidence_kind": "live_capture",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-12T11:53:07.844Z",
  "live_status": null,
  "messaging": [],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Aquinox Pharmaceuticals",
      "record": "https://startuphistory.org/c/aqxpharma.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "ADARx Pharmaceuticals",
      "record": "https://startuphistory.org/c/adarx.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "Apogee Therapeutics",
      "record": "https://startuphistory.org/c/apogeetherapeutics.com",
      "basis": "description_similarity",
      "category": null
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Aquinnah Pharmaceuticals” company record, https://startuphistory.org/c/aquinnahpharma.com"
}